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Background: Currently approved vascular closure devices (VCD) are recommended for use in common femoral artery (CFA) only. StarClose™ 
vascular system (SC) is a unique VCD that utilizes an extra luminal nitinol clip without an intravascular component, a feature that may allow safe use 
in small caliber vessels distal to CFA bifurcation.
Objective: To determine immediate efficacy and long term safety of SC for hemostasis of arterial punctures distal to CFA bifurcation.
Methods: Consecutive patients with arterial puncture distal to CFA bifurcation received SC after PCI. Baseline characteristics, procedural details 
and clinical outcomes were prospectively collected. Patients were ambulated 4-6 hours post PCI and adequacy of groin hemostasis and presence of 
vascular complication determined before hospital discharge. Clinical follow up and duplex ultrasound examination (DUS) of SC site was completed 
at 6-8 months to assess long term safety.
Results: A total of 106 patients undergoing PCI were included in the study. Mean age was 66±12 years and 63% were male. 93 (88%) patients 
received adjunctive glycoprotein IIb/IIIa platelet receptor antagonist or bivalirudin and 103 (97%) received a stent. The arterial puncture was 
located in superficial femoral artery (SFA) in 76 (72%), profunda femoris artery (PFA) in 22 (21%) and was undetermined in 8 (7%) patients. 
The mean diameter of CFA was significantly greater than its distal branch with SC (6.2±1.5 vs 4.5±1.0 mm for CFA and SC branch respectively, 
p<0.0001). SC was successful in 102 (96%) patients. At 24 hours, hematoma ≥5 cm was reported for 13 (12%) patients. No other major vascular 
event including access site bleeding, clinical evidence of pseudoaneurysm (PSA), arteriovenous fistula (AVF), local infection and neurological or 
vascular injury were observed. At a mean follow up of 9±2.5 months, there was no clinical evidence of arterial insufficiency or vascular complications 
by DUS and/or clinical assessment.
Conclusion: In patients undergoing PCI, placement of SC distal to CFA bifurcation results in effective immediate hemostasis and does not 
adversely affect arterial morphology or blood flow on long term follow up.
